Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

ABOUT THE DISEASE What is Osteoporosis? Osteoporosis is a disease that slowly, quietly weakens bones, often going undiagnosed – even when it breaks them. Osteoporosis is caused by low bone […]

It is possible to travel safely and enjoyably with osteoporosis, but there are precautions that need to be taken, as well as those related to the pandemic. More tips and […]

What is osteoporosis? THE “SILENT THIEF” Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Known as […]

Each year, Alberta Health Services (the province wide, fully-integrated health system in Alberta) recognizes exceptional accomplishments by teams across the province through the President’s Excellence Awards.  Alberta’s Fracture Liaison Service […]

BC Advocacy Osteoporosis Canada with the BCCOP and MedAccess BC are working together to advocate for British Columbians at high risk of osteoporotic fracture to have their medication/treatments publicly funded. […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

The B.C. Ministry of Health is conducting a survey of patients, caregivers, and advocacy groups to achieve input regarding osteoporosis therapies in British Columbia and B.C. PharmaCare coverage. We know […]

In celebration of Canada’s 150th anniversary, Their Royal Highnesses, The Prince of Wales and The Duchess of Cornwall were in attendance for many festivities in Ottawa on July 1st.